The U.S. Food and Drug Administration has granted orphan drug designation to the investigational therapy MNV-201 for patients with myelodysplastic syndrome, a serious, age-related blood disorder that ...

Orphan drug designation provides benefits such as tax credits, PDUFA fee waivers, and 7 years of market exclusivity upon ...

DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while ...

Kishore Ranjan says Software delivery is not just a support function; it's a core enabler of performance, reliability, and ...

Clinical validation from the Busch Center highlights the proven, scalable innovation driving a paradigm shift in prostate care - delivering precision treatment and better patient outcomes ...

DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell ...

In the field of renewable energy, biogas production via anaerobic digestion represents a critical area for sustainable ...

Caltech scientists have created a fully reusable enzyme-free DNA computing system—unlocking new possibilities for autonomous ...

Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets ...

Stop fearing 'No' and build your empire. 'By embracing rejection, you gain clarity, data and a stronger team, paving the way for inevitable growth,' Mamaearth Co-Founder Ghazal Alagh tells aspiring ...

Detailed price information for Alto Neuroscience Inc (ANRO-N) from The Globe and Mail including charting and trades.